Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Genetic Technologies.
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Health Check: ‘Cannabis corner’ in the green with record revenues and favourable deals
Health & Biotech
ASX Health Stocks: PYC to start trials for rare eye disease; OncoSil device successful in tumour removal
Health & Biotech
ASX Health Stocks: GTG pivots to US, vows to build a more efficient business
Health & Biotech
ASX Health Stocks: GTG’s GeneType Test can identify 80pc of people with risk of serious disease
News
Top 10 at 11: This morning is all about techies and goldies and bears, oh my!
Health & Biotech
ASX Health Stocks: Cleo up 30pc and GTG up 13pc after cancer test kit progress
News
Top 10 at 10: REE-nergised rare earths explorers, biotech standouts lead Wednesday’s winners
Health & Biotech
ASX Health Stocks: GTG to establish pilot program in US using its geneType Breast Cancer Risk Test
News
ASX Small Caps and IPO Weekly Wrap: Does anyone else want to pretend this week didn’t happen?
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Lessons aplenty as ASX dives on Day 2, while lithium upstart Wildcat Resources takes +2796pc out of 2023
News
ASX Small Caps Lunch Wrap: Who’s given up trying to turn themselves into an alien this week?
News
Top 10 at 10: M&A, high grade niobium, and another cap raise
Top 10 at 11: Liontown snaps back to harsh sub-$2 reality while Tesoro continues to climb
Health & Biotech
ASX Biotech September Winners: Healthcare down 5pc, but experts say it’s still best sector in a recession
Health & Biotech
